Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Crossover Study of Transdermal, Continuous Oxygen Therapy for Surgical Site Wound Healing in High- Risk Subjects Undergoing Lower Extremity Revascularization

NCT03746132 is registered in ClinicalTrials.gov with Neogenix, LLC dba Ogenix as lead sponsor.

NCT NCT03746132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03746132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Crossover Study of Transdermal, Continuous Oxygen Therapy for Surgical Site Wound Healing in High- Risk Subjects Undergoing Lower Extremity Revascularization
Lead sponsor
Neogenix, LLC dba Ogenix
Phase
Not applicable
Overall status
Unknown status
Start date
March 7, 2019
Completion date
July 31, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

incision, lower extremity, revascularization, surgical wound healing